| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.6 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.6 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |